110535 ⎘
ssDNA viruses; Details; Parvoviridae; Dependovirus, e.g. adenoassociated viruses Viruses as such, e.g. new isolates, mutants or their genomic sequences
LACTAM-MODIFIED ADENO-ASSOCIATED VIRUS VECTORS
#2COMPOSITIONS AND METHODS FOR TREATING DUCHENNE MUSCULAR DYSTROPHY
#3ADENO-ASSOCIATED VIRUS VARIANT
#4NUCLEIC ACID CONSTRUCTS FOR VA RNA TRANSCRIPTION
#5NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS HAVING REDUCED CAPSID DEAMIDATION AND USES THEREFOR
#6AAV VECTORS PRODUCED BY INSECT CELLS COMPRISING REP52 AND REP78 CODING SEQUENCES WITH DIFFERENTIAL CODON BIASES
#7METHOD FOR PRODUCING HIGH YIELD AND HIGH QUALITY RECOMBINANT ADENO-ASSOCIATED VIRUS
#8CHIMERIC AAV AND USES THEREOF
#9MODULAR SYSTEM FOR GENE AND PROTEIN DELIVERY BASED ON AAV
#10COMPOSITIONS USEFUL IN TREATMENT OF METACHROMATIC LEUKODYSTROPHY
#11NOVEL METHODS AND COMPOSITION OF AAV VECTORS FOR THE TREATMENT OF FRIEDREICH'S ATAXIA
#12COMPOSITIONS FOR RESTORING MECP2 GENE FUNCTION AND METHODS OF USE THEREOF
#13Methods for Delivery of Polynucleotides by Adeno-Associated Virus for Lysosomal Storage Disorders
#14Compositions and Methods for Enhanced Production of Adeno-Associated Virus
#15Gene Therapy For Neurodegenerative Disorders
#16ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY
#17ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS AND METHODS OF USE THEREOF
#18ADENO-ASSOCIATED VIRUS VECTOR VARIANTS FOR HIGH EFFICIENCY GENOME EDITING AND METHODS THEREOF
#19MODULATORY POLYNUCLEOTIDES
#20MODIFIED AAV CAPSID PROTEIN AND USE THEREOF
#21RECOMBINANT ADENO-ASSOCIATED VIRUS (RAAV) GENOME AND SINGLE-POLARITY RAAV VECTOR PACKAGED THEREBY
#22ADENO-ASSOCIATED VIRUS WITH ENGINEERED CAPSID
#23TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS) PRODUCED BY HUMAN NEURAL OR GLIAL CELLS
#24ENGINEERED CELL LINES FOR INCREASED PRODUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS (RAAV)
#25PRODUCER CELL, MANUFACTURING METHOD OF PRODUCER CELL, AND MANUFACTURING METHOD OF ADENO-ASSOCIATED VIRUS
#26AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
#27Method of Harvesting Biologics
#28BOCAPARVOVIRUS SMALL NONCODING RNA AND USES THEREOF
#29HIGH ACTIVITY REGULATORY ELEMENTS
#30Gene Therapy For Neurodegenerative Disorders
#31SYNTHETIC GENETIC ELEMENTS FOR BIOMANUFACTURE
#32Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism
#33AAV9-MEDIATED GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE I
#34MODIFIED AAV CAPSIDS AND USES THEREOF
#35REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE
#36VIRUS RECOVERY METHOD
#37RECOMBINANT AAV VECTORS EXPRESSING OSTEOPROTECTIVE GENES, INCLUDING HAS2 AND LUBRICIN, USEFUL IN THE TREATMENT OF OSTEOARTHRITIS AND RELATED JOINT CONDITIONS IN MAMMALS
#38RECOMBINANT ADENO-ASSOCIATED VIRUS HAVING VARIANT CAPSID, AND APPLICATION THEREOF
#39RAAV-BASED COMPOSITIONS AND METHODS
#40COMPOSITIONS AND METHODS FOR RECOMBINANT PARVOVIRUS PRODUCTION
#41METHODS OF REDOSING GENE THERAPY VECTORS
#42AAV COMPOSITIONS HAVING HIGH EXPRESSION LEVELS IN BRAIN
#43COMPOSITIONS AND METHODS FOR RECOMBINANT PARVOVIRUS PRODUCTION
#44NOVEL ADENO-ASSOCIATED VIRUS (AAV) CLADE F VECTOR AND USES THEREFOR
#45Adeno-associated virus compositions for targeted gene therapy
#46Adeno-associated virus with engineered capsid
#47AAV TREATMENT OF HUNTINGTON’S DISEASE
#48ADENO-ASSOCIATED VARIANTS, FORMULATIONS AND METHODS FOR PULMONARY DELIVERY
#49RECOMBINANT ADENO-ASSOCIATED VIRUS PARTICLE PURIFICATION WITH MULTIPLE-STEP ANION EXCHANGE CHROMATOGRAPHY
#50Adeno-Associated Virus Factor VIII Vectors, Associated Viral Particles and Therapeutic Formulations Comprising the Same
#51Gene Therapy For Neurodegenerative Disorders
#52GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS IIIB
#53VECTORS WITH MODIFIED INITIATION CODON FOR THE TRANSLATION OF AAV-REP78 USEFUL FOR PRODUCTION OF AAV
#54RATIONAL POLYPLOID ADENO-ASSOCIATED VIRUS VECTORS FOR THE TREATMENT OF DISEASE
#55EXPRESSION CASSETTE OF GENE COMPRISING OVERLAPPING OPEN READING FRAMES AND APPLICATION THEREOF IN INSECT CELL
#56ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF
#57Compositions and methods for delivery of AAV
#58Methods of predicting ancestral virus sequences and uses thereof
#59GENE THERAPIES FOR LYSOSOMAL DISORDERS
#60Adeno-associated virus variant capsids and methods of use thereof
#61AAV VECTORS TARGETED TO THE CENTRAL NERVOUS SYSTEM
#62Adeno-associated variants, formulations and methods for pulmonary delivery
#63Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
#64TREATMENT OF GLYCOGEN STORAGE DISEASE III
#65METHODS AND COMPOSITIONS FOR THE PURIFICATION OF ADENO-ASSOCIATED VIRUS
#66MODIFIED NUCLEIC ACIDS ENCODING ASPARTOACYLASE (ASPA) AND VECTOR FOR GENE THERAPY
#67Gene therapy for neurodegenerative disorders
#68Gene therapy for neurodegenerative disorders
#69PROSTATE TARGETING ADENO-ASSOCIATED VIRUS SEROTYPE VECTORS
#70SYSTEM AND METHOD FOR PROCESSING VIRUS PREPARATIONS TO REDUCE HETEROGENEITY
#71LACTAM-MODIFIED ADENO-ASSOCIATED VIRUS VECTORS
#72ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF
#73Adeno-associated virus virions with variant capsid and methods of use thereof
#74Adeno-associated virus virions with variant capsid and methods of use thereof
#75ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING PAH GENE FUNCTION AND METHODS OF USE THEREOF
#76REGULATABLE EXPRESSION SYSTEMS
#77CHEMICALLY-MODIFIED ADENO-ASSOCIATED VIRUS
#78Modified AAV capsid proteins and uses thereof
#79AAV VECTORS PRODUCED BY INSECT CELLS COMPRISING REP52 AND REP78 CODING SEQUENCES WITH DIFFERENTIAL CODON BIASES
#80Adeno-associated virus variant capsids and methods of use thereof
#81Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof
#82EXPRESSION VECTOR AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2
#83COMPOSITIONS USEFUL IN TREATMENT OF METACHROMATIC LEUKODYSTROPHY
#84Peptide-Modified Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism and Increased Muscle Transduction
#85Modified AAV capsids and uses thereof
#86Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#87RAAV-based compositions and methods
#88RAAV WITH CHEMICALLY MODIFIED CAPSID
#89ADENO-ASSOCIATED VIRUS WITH ENGINEERED CAPSID
#90small noncoding RNA and uses thereof
#91Nucleic acid constructs for VA RNA transcription
#92Modulatory polynucleotides
#93DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9
#94ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY
#95RECOMBINANT ADENO-ASSOCIATED VIRUS PARTICLE PURIFICATION WITH MULTIPLE-STEP ANION EXCHANGE CHROMATOGRAPHY
#96Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#97Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#98Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#99METHODS OF PREDICTING ANCESTRAL VIRUS SEQUENCES AND USES THEREOF
#100AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
#101AAV treatment of Huntington's disease
#102Adeno-associated variants, formulations and methods for pulmonary delivery
#103NUCLEIC ACID MOLECULES AND METHODS FOR AAV VECTOR SELECTION
#104Adeno-associated virus variant capsids and methods of use thereof
#105RECOMBINANT ADENO-ASSOCIATED VECTORS
#106Adeno-associated virus virions with variant capsids and methods of use thereof
#107COMPOSITIONS AND METHODS FOR DELIVERY OF AAV
#108COMPOSITIONS AND METHODS FOR TREATING GM1 GANGLIOSIDOSIS AND OTHER DISORDERS
#109AAV CAPSID PROTEINS FOR NUCLEIC ACID TRANSFER
#110ENGINEERED NUCLEIC ACID CONSTRUCTS ENCODING AAV PRODUCTION PROTEINS
#111METHOD OF QUANTITATIVE MEASUREMENT OF PARTICLE CONTENT USING HYDRATED STATE IMAGING
#112AADC polynucleotides for the treatment of Parkinson's disease
#113DNA IMPURITIES IN A COMPOSITION COMPRISING A PARVOVIRAL VIRION
#114Compositions and methods for modulating transduction efficiency of adeno-associated viruses
#115ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#116AAV VP1U CHIMERAS
#117METHODS AND COMPOSITIONS FOR MODULATING CELLULAR AGING
#118METHOD OF DETECTING AND/OR IDENTIFYING ADENO-ASSOCIATED VIRUS (AAV) SEQUENCES AND ISOLATING NOVEL SEQUENCES IDENTIFIED THEREBY
#119Adeno-associated virus virions with variant capsid and methods of use thereof
#120rAAV with chemically modified capsid
#121MUTANT OF ADENO-ASSOCIATED VIRUS (AAV) CAPSID PROTEIN
#122FURTHER IMPROVED AAV VECTORS PRODUCED IN INSECT CELLS
#123RAAV with chemically modified capsid
#124ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#125Compositions and methods for delivery of AAV
#126COMPOSITIONS AND METHODS FOR TREATING DUCHENNE MUSCULAR DYSTROPHY
#127Rational polyploid adeno-associated virus vectors for the treatment of disease
#128Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
#129Adeno-associated virus compositions for restoring PAH gene function and methods of use thereof
#130NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS HAVING REDUCED CAPSID DEAMIDATION AND USES THEREFOR
#131AAV capsid polynucleotides and polypeptides and virions containing the same
#132Hybrid recombinant adeno-associated virus serotype between AAV9 and AAVrh74 with reduced liver tropism
#133Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
#134Methods for Adeno-Associated Viral Vector Production
#135Modified AAV capsid proteins and uses thereof
#136Synthetic genetic elements for biomanufacture
#137Adeno-associated virus virion for treatment of Tay-Sachs disease and Sandhoff disease
#138MODULAR SYSTEM FOR GENE AND PROTEIN DELIVERY BASED ON AAV
#139NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS HAVING REDUCED CAPSID DEAMIDATION AND USES THEREFOR
#140GENE THERAPY FOR NEURODEGENERATIVE DISORDERS
#141METHODS OF REDOSING GENE THERAPY VECTORS
#142RAAV-based compositions and methods
#143Methods and materials for NT-3 gene therapy
#144Variant AAV capsids for intravitreal delivery
#145Methods of viral neutralizing antibody epitope mapping
#146Methods of predicting ancestral virus sequences and uses thereof
#147ACTIVITY-DEPENDENT EXPRESSION CONSTRUCTS AND METHODS OF USING THE SAME
#148Gene therapies for lysosomal disorders
#149DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9
#150Gene therapy for mucopolysaccharidosis IIIB
#151Treatment of glycogen storage disease III
#152MODIFIED CLOSED-ENDED DNA (CEDNA)
#153Gene therapies for lysosomal disorders
#154Gene therapies for lysosomal disorders
#155Adeno-associated virus variant capsids and methods of use thereof
#156Compositions and methods for transient delivery of nucleases
#157High activity regulatory elements
#158ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF
#159Recombinant AAV vectors expressing osteoprotective genes, including HAS2 and lubricin, useful in the treatment of osteoarthritis and related joint conditions in mammals
#160Compositions comprising AAV expressing dual antibody constructs and uses thereof
#161AAV vectors targeted to the central nervous system
#162Modulatory polynucleotides
#163GENE THERAPY FOR ALZHEIMER'S AND OTHER NEURODEGENERATIVE DISEASES AND CONDITIONS
#164Adeno-associated virus compositions for targeted gene therapy
#165ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#166Compositions and methods of treating Huntington's disease
#167Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cells
#168AAV9-mediated gene therapy for treating mucopolysaccharidosis type I
#169Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV
#170Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#171Methods of predicting ancestral virus sequences and uses thereof
#172Rational polyploid adeno-associated virus vectors for the treatment of disease
#173Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#174AAV treatment of Huntington's disease
#175Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#176Gene therapies for lysosomal disorders
#177Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the same
#178Adeno-associated virus (AAV) clade f vector and uses therefor
#179Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery
#180Recombinant AAV variants and uses thereof
#181Liver targeting adeno-associated viral vectors
#182Modified AAV capsid proteins and uses thereof
#183Mutant of adeno-associated virus (AAV) capsid protein
#184Methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders
#185RAAV with chemically modified capsid
#186AAV vectors targeted to the central nervous system
#187AADC polynucleotides for the treatment of Parkinson's disease
#188AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY
#189Bocaparvovirus small noncoding RNA and uses thereof
#190Method of quantitative measurement of particle content using hydrated state imaging
#191Compositions comprising AAV expressing dual antibody constructs and uses thereof
#192AAV virions with decreased immunoreactivity and uses therefor
#193ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING PAH GENE FUNCTION AND METHODS OF USE THEREOF
#194Adeno-associated virus virions with variant capsid
#195RAAV-based compositions and methods
#196AAV vectors produced by insect cells comprising REP52 and REP78 coding sequences with differential codon biases
#197Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
#198Adeno-associated virus polynucleotides, polypeptides and virions
#199Methods of predicting ancestral virus sequences and uses thereof
#200Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#201Compositions comprising AAV expressing dual antibody constructs and uses thereof
#202DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9
#203Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#204Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#205Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#206AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
#207AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
#208AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
#209AAV with unique capsid protein VP1 and methods of using for treatment
#210Methods for adeno-associated viral vector production
#211Prostate-targeting adeno-associated virus serotype vectors
#212MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF
#213Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
#214Chimeric adeno-associated virus/ bocavirus parvovirus vector
#215AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
#216Method for producing non-enveloped viral particles
#217RAAV-BASED COMPOSITIONS AND METHODS
#218Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
#219AAV capsid proteins for nucleic acid transfer
#220AAV mediated influenza vaccines
#221Products and Methods for Delivery of Polynucleotides by Adeno-Associated Virus for Lysosomal Storage Disorders
#222Compositions and methods for transient delivery of nucleases
#223Modified AAV capsids and uses thereof
#224AAV treatment of Huntington's disease
#225Compositions and method for reducing seizures
#226Mutated structural protein of a parvovirus
#227rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes
#228Compositions and methods for transient delivery of nucleases
#229DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9
#230Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#231Recombinant AAV variants and uses thereof
#232ANTI-TAU CONSTRUCTS
#233RAAV-BASED COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTI-TRYPSIN DEFICIENCIES
#234AAV vectors targeted to the central nervous system
#235Further improved AAV vectors produced in insect cells
#236AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY
#237AADC polynucleotides for the treatment of parkinson's disease
#238DNA impurities in a composition comprising a parvoviral virion
#239Modulatory polynucleotides
#240Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#241Methods of predicting ancestral virus sequences and uses thereof
#242Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#243AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
#244ADENO-ASSOCIATED VIRUS VECTOR VARIANTS FOR HIGH EFFICIENCY GENOME EDITING AND METHODS THEREOF
#245Recombinant AAV Vectors Expressing Osteoprotective genes, including HAS2 and Lubricin, useful in the Treatment of Osteoarthritis and Related Joint Conditions in Mammals
#246RAAV-BASED COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTI-TRYPSIN DEFICIENCIES
#247Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#248VECTORS WITH MODIFIED INITIATION CODON FOR THE TRANSLATION OF AAV-REP78 USEFUL FOR PRODUCTION OF AAV
#249Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV
#250Adeno-associated virus factor VIII vectors, associated viral particles and therapeutic formulations comprising the same
#251Gene therapy for neurodegenerative disorders
#252Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
#253Compositions comprising AAV expressing dual antibody constructs and uses thereof
#254Methods of viral neutralizing antibody epitope mapping
#255RADIOLABELING OF ADENO ASSOCIATED VIRUS
#256Methods of predicting ancestral virus sequences and uses thereof
#257Enhanced AAV-mediated gene transfer for retinal therapies
#258Adeno-associated virus virions with variant capsid and methods of use thereof
#259Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#260Adeno-associated virus virions with variant capsid and methods of use thereof
#261Adeno-associated virus virions with variant capsid and methods of use thereof
#262rAAV-based compositions and methods
#263Recombinant virus products and methods for inhibition of expression of myotilin
#264Directed evolution and in vivo panning of virus vectors
#265Adeno-associated virus with site-directed mutagenesis and site-directed modification and preparation method and application thereof
#266Adeno-associated vectors for enhanced transduction and reduced immunogenicity
#267S100 based treatment of cardiac power failure
#268Methods of predicting ancestral virus sequences and uses thereof
#269Neutralization-resistant CDV mutants and viral vectors
#270RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
#271Adeno-associated virus virions with variant capsid and methods of use thereof
#272PRODUCTS AND METHODS FOR DELIVERY OF POLYNUCLEOTIDES BY ADENO-ASSOCIATED VIRUS FOR LYSOSOMAL STORAGE DISORDERS
#273Materials and methods for the treatment of pathological neovascularization in the eye
#274Proviral plasmids and production of recombinant adeno-associated virus
#275Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
#276RECOMBINANT VIRUS AND PREPARATIONS THEREOF
#277Chimeric adeno-associated virus/ bocavirus parvovirus vector
#278Self-complementary parvoviral vectors, and methods for making and using the same
#279Delivery of polynucleotides using recombinant AAV9
#280Vectors comprising stuffer/filler polynucleotide sequences and methods of use
#281AAV vectors produced by insect cells comprising REP52 and REP78 coding sequences with differential codon biases
#282Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same
#283AAV capsid proteins for nucleic acid transfer
#284Methods and compositions for treating Huntington's Disease
#285HYPOXIA REGULATED CONDITIONALLY SILENCED AAV EXPRESSING ANGIOGENIC INDUCERS
#286Adeno-associated virus (AAV) glades, sequences, vectors containing same, and uses therefor
#287Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV
#288Viruses associated with immunodeficiency and enteropathy and methods using same
#289Adeno-associated virus virions with variant capsid and methods of use thereof
#290Adeno-associated virus virions with variant capsid and methods of use thereof
#291Avian adenoassociated virus and uses thereof
#292VECTORS WITH MODIFIED INITIATION CODON FOR THE TRANSLATION OF AAV-REP78 USEFUL FOR PRODUCTION OF AAV
#293Mutant adeno-associated virus virions and methods of use thereof
#294EXPRESSION OF VIRUS ENTRY INHIBITORS AND RECOMBINANT AAV THEREFOR
#295Adeno-associated virus virions with variant capsid and methods of use thereof
#296Recombinant virus and preparations thereof
#297Adeno-associated virus virions with variant capsid and methods of use thereof
#298Bovine adeno-associated viral (BAAV) vector and uses thereof
#299Baculoviral vectors comprising repeated coding sequences with differential codon biases
#300Viral vectors with modified transduction profiles and methods of making and using the same